Greyhound Neuropathy Testing: Essential Guide for American Breeders

Greyhound neuropathy (GN), often called polyneuropathy, is a genetic neurological disorder found only in Greyhounds and mixed-breed dogs with Greyhound lineage. This hereditary disease commonly shows signs in puppies between three and nine months old and can be devastating for affected dogs.

Dogs suffering from GN typically display muscle weakness, reduced exercise stamina, and a characteristic "bunny-hopping" gait. The disease progresses rapidly, leading to muscle wasting, loss of coordination, and changes in vocalization that can impact their ability to bark. Unfortunately, most pups affected by this condition do not live past their first year due to severe symptoms and the lack of a cure.

The Greyhound community in the United States, including reputable organizations and veterinary professionals, strongly advocates for genetic testing of breeding dogs. This screening helps identify carriers and affected animals, enabling breeders to make informed, ethical decisions that prevent spreading GN in the breed.

Understanding Greyhound Neuropathy

Greyhound neuropathy is caused by a mutation in the NDRG1 gene. Research indicates that approximately 25% of Greyhounds in show lines in the U.S. may carry this mutation, though it is less common in racing lines. Since GN is inherited rather than contagious, it is passed down through breeding.

Symptoms can first appear as early as 12 weeks of age. As the disorder worsens, dogs may struggle with breathing difficulties, significant muscle loss, and a declining quality of life, which often leads to humane euthanasia to ease suffering.

Who Is at Risk?

The condition specifically affects Greyhounds and crossbred dogs with Greyhound ancestry. Signs typically show up before the pup reaches one year old, with most dogs not surviving beyond this due to the progressive nature of the disease.

Importantly, some dogs may be carriers of the mutated gene without exhibiting any symptoms. These asymptomatic carriers can still pass on the defect to their offspring, underscoring the importance of genetic testing in breeding decisions.

Genetics Behind the Disease

GN follows an autosomal recessive inheritance pattern, which means a dog must inherit two copies of the mutated gene (one from each parent) to develop the disease. The breeding outcomes depend on the genetic makeup of the parents:

• If neither parent carries or has the mutation, offspring will be free of the gene.
• If one parent is a carrier and the other is clear, about half the litter will be carriers and half will be clear.
• If one parent is affected and the other is clear, all offspring will be carriers.
• If both parents are carriers, approximately 25% of the pups may be affected, 50% carriers, and 25% clear.
• If one parent is affected and the other is a carrier, half the puppies may be affected and half carriers.
• If both parents are affected, all offspring are predicted to be affected.

How to Test Your Greyhound

Testing your breeding Greyhounds for neuropathy gene mutations is vital for making responsible breeding choices that help safeguard the breed’s health.

The test typically involves DNA sampling via a cheek swab or blood draw performed by your veterinarian. Samples are sent to certified genetic testing labs, with results often available within one to three weeks.

In the U.S., trusted laboratories like AnimaLabs provide reliable and specific testing for Greyhound polyneuropathy. Some private labs offer expedited processing and comprehensive genetic counseling for breeders. It’s recommended to choose labs experienced with this gene mutation and consult your veterinary geneticist or neurologist for guidance.

To locate authorized testing services, breeders in the U.S. can visit veterinary genetic service providers such as AnimaLabs or Wisdom Panel, which support testing for this mutation.

Why Genetic Testing Is Crucial for Breeders

Because GN profoundly affects the well-being and survival of puppies, breeding strategies must focus on health first. Preventing the mating of two carriers is critical to avoiding affected puppies.

Genetic testing allows breeders to classify their dogs as:

• Clear: No mutation, safe for breeding.
• Carrier: One copy of the gene mutation, no symptoms but can pass mutation on.
• Affected: Two copies of the mutation, likely to develop the disease.

Responsible breeding calls for pairing carriers only with clear dogs to prevent affected pups and working toward increasing the population of clear dogs over time to reduce gene frequency.

Genotypes and Breeding Outcomes

Final Thoughts

Progressive Greyhound neuropathy is a severe inherited condition that appears during early puppyhood and unfortunately has no current cure. Prevention through informed breeding decisions is the most effective way to protect the breed.

Genetic testing makes it possible to identify carriers and affected dogs, empowering breeders to plan matings that avoid producing affected puppies. Working with local veterinarians and specialized genetic labs ensures the best care and informed choices.

U.S. breeders and owners should prioritize testing their breeding Greyhounds through reputable laboratories, using vet-collected samples, to ensure healthy generations of this distinguished breed in America.